Table 2.

Effect of probiotics supplementation at T3, based on route of delivery.

Effect of probiotics supplementation based on route of delivery
	Vaginal delivery			Caesarean section
	Probiotic Median (IQR, range) N = 9	Placebo Median (IQR, range) N = 6	P value	Probiotic Median (IQR, range) N = 9	Placebo Median (IQR, range) N = 12	P value
Sum of relative abundance of potentially pathogenic families at T3	49.1 (25.9–67.4)	74.2 (49.6–89.8)	0.37	52.5 (44.2–67.7)	58.4 (51.2–95.9)	0.39
Relative abundance of Bifidobacteriaceae at T3	42.8 (23.7–55.2)	0.05 (0.03–12.9)	0.049	33.7 (28.9–45.4)	0.03 (0.01–1.51)	0.001
Total SCFA levels at T3 (μg per gram of wet faeces)	2254 (IQR: 1915–2668); range: 1243–5152	1529 (IQR: 1349–2208); range: 723–2647	0.18	2598 (IQR: 1588–2786); range: 1399–3388	1725 (IQR: 1092–2135); range: 426–2723	0.034

Bold values indicate statistical significance p < 0.05.

IQR interquartile range, SCFA short-chain fatty acid, T3 two weeks after commencing supplementation.